Atomi Financial Group Inc. Has $361,000 Stock Holdings in Synopsys, Inc. (NASDAQ:SNPS)

Atomi Financial Group Inc. lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 53.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 632 shares of the semiconductor company’s stock after purchasing an additional 221 shares during the period. Atomi Financial Group Inc.’s holdings in Synopsys were worth $361,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of SNPS. Bay Harbor Wealth Management LLC acquired a new stake in shares of Synopsys during the first quarter worth $26,000. University of Texas Texas AM Investment Managment Co. acquired a new stake in shares of Synopsys during the fourth quarter worth $28,000. Jones Financial Companies Lllp raised its position in shares of Synopsys by 233.3% during the fourth quarter. Jones Financial Companies Lllp now owns 60 shares of the semiconductor company’s stock worth $31,000 after purchasing an additional 42 shares during the period. Activest Wealth Management acquired a new stake in shares of Synopsys during the first quarter worth $35,000. Finally, Hazlett Burt & Watson Inc. grew its holdings in shares of Synopsys by 40.0% during the first quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock valued at $40,000 after buying an additional 20 shares in the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.

Synopsys Stock Performance

Shares of NASDAQ SNPS traded up $2.89 during mid-day trading on Monday, reaching $616.94. 307,436 shares of the company traded hands, compared to its average volume of 1,060,994. The stock has a market cap of $94.53 billion, a PE ratio of 67.13, a price-to-earnings-growth ratio of 3.96 and a beta of 1.07. The company’s fifty day moving average is $586.10 and its two-hundred day moving average is $561.15. Synopsys, Inc. has a fifty-two week low of $418.51 and a fifty-two week high of $629.38.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, May 22nd. The semiconductor company reported $3.00 earnings per share for the quarter, missing the consensus estimate of $3.03 by ($0.03). Synopsys had a net margin of 23.05% and a return on equity of 22.66%. The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the previous year, the company earned $1.76 EPS. Synopsys’s revenue for the quarter was up 15.2% compared to the same quarter last year. Research analysts forecast that Synopsys, Inc. will post 9.66 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. JPMorgan Chase & Co. upped their price target on Synopsys from $650.00 to $655.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Piper Sandler upped their price target on Synopsys from $672.00 to $687.00 and gave the company an “overweight” rating in a research report on Wednesday, July 10th. Needham & Company LLC reissued a “buy” rating and set a $660.00 price target on shares of Synopsys in a research report on Thursday, May 23rd. KeyCorp upped their price target on Synopsys from $675.00 to $690.00 and gave the company an “overweight” rating in a research report on Thursday, June 27th. Finally, Rosenblatt Securities reissued a “buy” rating and set a $615.00 price target on shares of Synopsys in a research report on Thursday, May 23rd. Eleven analysts have rated the stock with a buy rating, According to MarketBeat, Synopsys presently has an average rating of “Buy” and an average target price of $627.18.

Insider Activity at Synopsys

In related news, Director Mercedes Johnson sold 5,500 shares of the stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $581.38, for a total transaction of $3,197,590.00. Following the completion of the sale, the director now owns 1,543 shares in the company, valued at approximately $897,069.34. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Synopsys news, Director Mercedes Johnson sold 5,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $581.38, for a total value of $3,197,590.00. Following the completion of the sale, the director now owns 1,543 shares in the company, valued at approximately $897,069.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Sassine Ghazi sold 10,294 shares of the firm’s stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $582.41, for a total value of $5,995,328.54. Following the completion of the sale, the chief executive officer now owns 62,568 shares of the company’s stock, valued at approximately $36,440,228.88. The disclosure for this sale can be found here. Insiders sold a total of 80,870 shares of company stock worth $49,055,307 in the last 90 days. 0.66% of the stock is owned by company insiders.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.